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ABSTRACT 
We previously reported that zinc deficiency predisposes the lung 
epithelium to apoptosis during conditions of inflammatory stress.1 Human zinc 
transporters comprise a family of 24 proteins and have a primary role in zinc 
homeostasis.  All 24 transporters were examined in human epithelial cells and 
shown to have consistent levels of expression from donor to donor.2  We have 
previously observed that primary cultures of human upper airway epithelia 
obtained from multiple human donors exhibit a marked induction in SLC39A8 
gene expression when exposed to the inflammatory cytokine tumor necrosis 
factor alpha (TNFα).  In sharp contrast, expression of all other zinc transporters 
remains largely unchanged. Therefore, we contend that genetic variability in 
SLC39A8 may confer changes in zinc regulation leading to differences in inter-
individual variation in response to inflammatory stress. 
The NIH SNP database was used to identify two candidate SNPs of high 
frequency (<40%) in the 3’ UTR region (rs.9331& rs.9705) and one 
nonsynonymous SNP in the exon region (rs.13107325) of SLC39A8. Using PCR 
amplification and restriction enzyme digestion, 89 human small bowel samples 
were genotyped for each SNP. A SNaPshot assay was used to identify cis-acting 
genetic variability, in the form of allelic expression imbalance (AEI), in all 
heterozygous samples for each SNP. The promoter region was studied in silico 
to identify SNPs that harbored within transcription factor binding sites (TFBs). 
SnaPshot analysis revealed allelic imbalance in 1 sample out of a total of 28 
heterozygous samples (obtained from 89 original donors).  
The overall frequency of cis-acting dysfunction in SLC39A8 gene 
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expression appears to be minimal, but conditions in cytokine induced cells as 
well as lung epithelial cells remains to be studied. The promoter region shows 
that candidate SNPs do exist within putative TFBs and will be evaluated in future 
studies. 
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INTRODUCTION 
 Pulmonary diseases such as asthma and adult respiratory distress 
syndrome (ARDS) are a substantial burden to patients and society.  Despite 
recent advances in medical research, the pathogenesis of these disorders are 
still not fully understood.  Therefore, further investigation in this area is 
warranted.  A common phenomenon observed in individuals with acute lung 
injury is degradation of the lung epithelium, a critical cellular barrier that protects 
the lung from the outer environment and maintains the ability on the host to 
ventilate.1 In an attempt to understand the cause of lung epithelial cell damage, 
experiments have recently been conducted in the laboratory of my faculty 
supervisor demonstrating that zinc depletion induces cell apoptosis, also known 
as programmed cell death, and breakdown of the epithelial barrier.1 The study 
showed that lung epithelial cells require zinc in order to tolerate an inflammatory 
environment and perhaps more importantly, that zinc supplementation protects 
cells from experiencing an untimely death. Therefore it is evident that zinc plays 
an important role in helping epithelial cells avoid apoptosis when in a hostile 
environment. In studies that I initiated, we observed that primary human lung 
epithelial cells possess an intricate system composed of 24 different zinc 
transporters that we presume allow these cells to maintain a critical intracellular 
zinc concentration. In general there are two major categories of zinc transporters.  
There are 14 zinc importers (SLC39A1 thru SLC39A14) reside on the cell 
membrane and transport zinc from the outside environment into the cell, and 10 
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zinc exporters (SLC30A1 thru SLC30A10) that function to export excess zinc out 
of the cell. In order to gain a better understanding of the role that these zinc 
transporters have within the epithelium, we developed a method to rapidly 
evaluate and quantify message RNA (mRNA) levels of all 24 zinc transporters in 
tandem. Primary lung epithelial cell cultures obtained from ten different human 
lung donors were screened for all 24 transporters in order to determine the 
amounts of mRNA expression of each gene. The results showed that the majority 
of all transporters were expressed across all donors to varying degree (Figure 1).  
We then conducted a similar experiment to measure the relative amounts of 
mRNA present when the cells were exposed to inflammatory cytokines, known to 
be upregulated in the lung environment during ARDS, as well as zinc deprivation. 
When cells were treated with Tumor Necrosis Factor-alpha (TNFα), a pro-
inflammatory cytokine that is expressed early in patients with acute lung injury 
and ARDS, we observed that the zinc importer SLC39A8 was consistently and 
substantially up-regulated while the mRNA levels of most other transporters 
remained relatively unchanged (Figure 2). With this information it became 
apparent that SLC39A8 may play a critical role in regulating intracellular zinc 
during inflammatory stress and that an inspection of this gene was warranted to 
determine if genetic variability, that is single nucleotide polymorphisms (SNPs), in 
either the promotion region, protein coding region, or 3’ untranslated region, 
could account for alteration in zinc homeostasis and disease susceptibility during 
inflammatory stress and the development of ARDS (Figure 3). A library of small 
bowel samples was used for further studies due to a limited amount of lung 
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tissue samples. The small bowel tissue contained the epithelium layer and was 
deemed readily suitable for our studies. 
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METHODS AND MATERIALS 
Genetic Material Sources. For both the genotyping analysis and the allelic 
expression imbalance (AEI) assay, DNA and mRNA (in the form of cDNA) were 
obtained from a library of 89 small intestine samples from human donors. 
Isolation of DNA and mRNA was done using standard isolation procedures. For 
validation of the GC clamp assay a library of Coriell Cell Line cells were used. 
Coriell Cell’s have been genetically mapped by the HapMap project. They were 
used to validate primer function because their genetic composition was known 
and readily available, as were the DNA samples from these cells. 
 
Primer Design.  Primer Express Software was used to design all primers. 
Guideline parameters for primer pairs were: i) amplification length of 50-150 
bases ii) a melting point temperature of 58-60°C. iii) GC percent between 20-80% 
iv) primer length of 12-30 bases. For GC primers, two forward primers were 
designed to be allele specific. Each forward primer extends up to and including 
the SNP. The 3rd base from the 5’ end of the primer was purposefully 
mismatched to the DNA sequence so as to ensure each primer’s allele specific 
amplification.  A 12 base long sequence of alternating G and C base pair was 
attached to only one forward primer. Forward primers were designed to minimize 
possible hairpin structures within each primer as well as dimer formation between 
the forward or reverse primers.  A common reverse primer was designed to 
amplify with both forward primers.   
 A separate pair of forward and reverse primers were designed for the AEI 
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assay for SNPs rs.9331 and rs.13107325. Using optimum parameters, the 
primers were designed to amplify a 50-150 bases long region around the SNP. 
Also primer extension (PE) primers were designed for each SNP. Each PE 
primer was a forward primer that ran up to 1 base prior to the SNP of interest. 
The optimum melting temperature for the PE primer was set between 50-55°C.  
 Site directed mutagenesis (SDM) primers were designed to introduce a 
Cytosine instead of an Adenosine, three bases downstream from the SNP site of 
rs. 9705. The reverse primer introduced the mutagenesis site, extending up to a 
base pair before the SNP site. The forward primer was used just to amplify the 
sequence surrounding the SNP. All primers were used at a concentration of 10 
µM in ddH2O. 
 
Genotyping.  Initially GC clamp assays were designed for all three candidate 
SNPs. Three different types of genotype samples were chosen (homozygous A, 
heterozygous, & homozygous G and homozygous T, heterozygous & 
homozygous C, respectively), for rs.9331 and rs.9705. For rs.13107325 a 
random assortment of three individual samples were chosen. Each genotype was 
then amplified with the SNP primer, the wild type (WT) primer as well as both at 
the same time. Amplification was done using Real Time-Polymerase Chain 
Reaction (RT-PCR). Each reaction contained 10 µL of SYBR Green master mix, 
8.8 µL of ddH2O, 0.6 µL of Forward primer (the SNP, WT or both), 0.6 µL of 
reverse primer, and 1.0 µL of DNA. The sample wells were incubated at 50°C for 
2 minutes, then at 95°C for 10 minutes, followed by 40 cycles of 95°C for 15 
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seconds, 60°C for 1 minute.  A dissociation curve was also ran. To determine if 
product amplified before a cycle threshold of 30 cycles, as well as exhibiting 
correct dissociation behavior by evaluating melting curve differences based on 
amplification with a GC- or non-GC allele specific primer.  
 For rs.9705, the GC clamp assay proved to be insufficient for genotyping 
so the samples were amplified with SDM primers to amplify the SNP region 
sequence. Amplification was done using RT-PCR. Each reaction contained 10 µL 
of SYBR Green master mix, 8.8 µL of ddH2O, 0.6 µL of forward primer, 0.6µL of 
reverse SDM primer, and 1.0 µL of DNA.  To each sample was added 1.0µL of 
BstZ17 I restriction enzyme and 1.0 µL of NEBuffer3. Samples were incubated at 
37°C overnight. Melting dissociation curves were run on all samples to observe 
differences in cut and un-cut product melting points. PCR products were then run 
on an agarose gel. Into each well was loaded 10 µL of PCR product (digested 
with enzyme) mixed with 2 µL of Orange tracking dye. One of the wells contained 
12 µL of DNA ladder for sizing purposes. The gel was run at 80V for 
approximately 30 minutes. The results were viewed in a chamber with ultraviolet 
light.  
Samples were then amplified in the same manner using a fluorescently 
labeled forward primer. PCR and digestion was conducted as previously 
described. The digested product was analyzed by capillary electrophoresis, using 
an ABI3730 instrument with a GeneScan 500 ROX standard in triplet repeats.  
This allowed us to determine peak size which correlated directly with base pair 
length, and genotype. 
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PCR Amplification. Heterozygous samples were amplified by standard PCR. 
Each sample well contained 7.5 µL of 2X Ready mix, 0.3 µL of forward primer, 
0.3 µL of reverse primer, 5.9 µL of ddH2O, and 1.0 µL of template (DNA or 
cDNA). The samples were denatured at 95°C for 2 minutes followed by 30 cycles 
of 95°C for 15 seconds, 60°C for 1 minute, and 72°C for 1 minute. To purify the 
products, exonuclease I (Exo I) was used to degrade residual single stranded 
primers. Bacterial Alkaline phosphatase (BAP) was used to prevent fragments 
from self-ligating. 1 µL of BAP, 0.1 µL of ExoI, and 1.4 µL of 10X buffer with Zinc 
was added to each reaction well. The samples were incubated at 37°C overnight 
and then incubated at 80°C for 15 minutes to inactivate the enzyme. 
 
Primer Extension Optimization . Optimization of SNaPshot buffer and the PE 
primer was done using amplified samples 1 and 2. A total of 4 different 
combinations were used with both samples. Reactions wells were as follows. 
Combination 1: 2.5 µL of SNaPshot buffer, 0.5 µL of PE primer, 1.5 µL of PCR 
product, and 0.5 µL of ddH2O. Combination 2: 2.5 µL of SNaPshot buffer, 0.25 
µL of PE primer, 1.5 µL of PCR product, and 0.75 µL of ddH2O. Combination 3: 
1.25 µL of SNaPshot buffer, 0.5 µL of PE primer, 1.5 µLof PCR product, and 1.75 
µL ddH2O. Combination 4: 1.25 µLof SNaPshot buffer, 0.25 µL of PE primer, 1.5 
µL of PCR product, and 2 µL of ddH2O. Each reaction well was denatured at 95C 
for 2 minutes, followed by 25 cycles of 95°C for 10 seconds then 55°C for 5 
seconds. 1 µL of Calf Intestinal Phosphatase (CIP) was added to each well, to 
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degrade any unincorporated fluorescently marked dideoxynucleotides (ddNTPs) 
and PE primers. The samples were incubated at 37°C overnight and then 
incubated at 80°C for 15 minutes to inactivate the enzyme. 
 
SNaPshot. Products from the PE optimization were run through a capillary 
electrophoresis instrument, ABI 3730, using LIZ120 standard. Ratios of peak 
areas were analyzed using the GeneMapper v3.70 program (ABI).  Analysis 
showed that Combination 3 provided optimal results therefore all further AEI was 
done using those parameters.  
 
Promoter Analysis: The SLC39A8 promoter sequence was retrieved using the 
UCSC genome browser (http://genome.ucsc.edu) in collaboration with Dr. Ilya 
Ioshkes. The genomic sequence and 10kb upstream from the gene start site 
were analyzed. The putative transcription factor binding sites (TFBS) were 
mapped using MatchTM Professional software developed by Biobase 
International GmbH "MATCHTM (A tool for searching transcription factor binding 
sites in DNA sequences" Nucleic Acids Res. 31, 3576-3579.) The search was 
performed with high-quality matrices and with cutoff parameters minimizing false 
negative predictions.  
 All TFBS were matched up to known SNPs in the UCSC database. SNPs 
existing at the chromosomal positions of the TFBS were noted by position, name 
(reference #) as well as heterozygosity when possible.  
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RESULTS 
 Our initial work of measuring mRNA levels in human donors showed that 
relative amounts of mRNA were very consistent donor to donor (Figure 1). This 
shows that the regulation of these transporters is very tight and it is most likely 
inflammatory conditions which incite differences between patients. Due to the 
validation of the primers’ capacities to amplify the sequences we were able to 
develop a semi-quantitative method of measuring relative mRNA levels that 
could be applied to both baseline and inflammatory conditions. Thus a consistent 
9 fold increase in SLC39A8 mRNA levels during TNF-α induction is indicative of 
the importance of this gene during stress (Figure 2). 
The first attempt using the GC clamp assay was not successful for any of 
the three SNPs. Not all samples were amplified to a sufficient amount (<30 cycle 
threshold) and dissociation curves did not show a clear distinction between 
genotypes. As a result, GC primers (Figure 4 a) were redesigned to improve 
amplification in the presence of the allele specific primers. The new primers were 
tested again with the Coriell Cell Line samples. Amplification and dissociation of 
the amplified product met criteria so we proceeded with genotyping of the small 
bowel samples (Figure 4 c). 
SNP rs.13107325 is not in the HapMap project so samples of known 
genotype were not readily available to sufficiently test the efficiency of the GC 
clamp assay. However, due to the low heterozygosity (4.2%) of this SNP, it was 
decided to use a primer that amplifies the SNP allele only, and therefore 
eliminating complications of amplification with two primers in the same sample.  
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Amplification with the SNP primer resulted in the identification of 7 samples 
(Figure 4 b) that were either heterozygous or homozygous for the SNP.  
All 7 samples were then amplified using fluorescent ddNTPs along with 
PE primers. The SNaPshot assay revealed that 1 sample (patient #19) was in 
fact homozygous T while the rest of the 6 samples were heterozygous. The 
average ratio of C to T allele levels was 0.2917 to 0.7083. Also the average 
standard deviation of mRNA levels from DNA levels was only 0.855% (Appendix 
C). The results show that none of the heterozygotes exhibited AEI (Figure 6 c).  
The standard GC clamp assay was used to genotype SNP rs.9331. Of the 
89 samples genotyped, 27 were heterozygous, 51 were homozygous A, 6 were 
homozygous G, and 5 were not able to be analyzed (Figure 6 a). The genotype 
was based on dissociation curves of the amplified products. Of all 27 
heterozygous samples, 24 were available for SNaPshot analysis. The results of 
the SNaPshot assay revealed that the DNA of all samples was consistently 
comprised of an average ratio of 0.4214 to 0.5785 G to A allele levels.  DNA 
levels from sample to sample were consistent, with an average standard 
deviation of 2.38%. Deviation of mRNA levels compared to DNA in the same 
patient was found to be even less with an average deviation, for all samples, of 
1.88% (Appendix A). This shows that the DNA is consistent from sample to 
sample as would be expected, since a 1:1 ratio ought to be observed, one from 
each allele. A ratio of 0.4214 to 0.5785 (of guanine to adenosine levels) was 
observed because the fluorescently labeled Adenosine fluoresces more strongly 
than the Guanine. 
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Of the 24 samples analyzed, 1 sample (sample #48) showed a consistent 
decrease in SNP mRNA levels compared to the DNA levels (Figure 7). The DNA 
ratio of G to A, (or SNP to WT) levels was 0.4374 to 0.5626. The mRNA ratio of 
G to A levels were on average 0.2972 to 0.7028. This is a 46% decrease in 
relative amounts of the G allele (the SNP allele) mRNA compared to DNA 
(Appendix A).  
 The GC clamp method could not be used to genotype SNP rs.9705. So 
the samples were genotyped using the restriction enzyme BstZ17I after 
introducing a mutagenesis site that allowed the samples to be distinguished by 
alleles. Samples were first amplified with non-fluorescent primers. DNA was then 
amplified using RT-PCR. The dissociation curves showed no distinguishable 
peaks between digested and undigested samples. When run on an agarose gel, 
band resolution was poor and we could no identify cut and uncut PCR products. 
Also, the smallest marker on the ladder was 100bp so smaller bands of 65 and 
40bp were hard to distinguish.  
 To overcome this, samples were again amplified with a fluorescently 
marked forward primer. After digestion and separation with capillary 
electrophoresis, genotyping was possible. Samples with the C allele exhibited a 
peak at 65bp, while samples with a T allele exhibited a peak at 40bp. 
Heterozygotes (with both a C and T allele) exhibited peaks at both lengths 
(Figure 5). Of the 89 samples analyzed, 48 were homozygous C (or WT), 10 
were homozygous T (or SNP), while 19 samples were heterozygous, and 12 
samples were not able to be analyzed (Figure 6 b).  
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 The SNaPshot assay was then conducted with standard procedure. An 
extra calf intestine phosphatase digestion was conducted to remove extraneous 
fragments that hindered data analysis. Upon the second run through capillary 
electrophoresis instrument, samples were analyzed and showed to be more 
variant than for either of the other two SNPs. The average C to T ratio was 
0.3980 to 0.6020, while the average standard deviation of DNA was a high at 
7.71%.  Variation of mRNA to DNA levels in the same patient was much lower, 
with an average standard deviation of 4.92% (Appendix B). Of all samples tested, 
no consistent deviation was observed in mRNA with respect to the patients DNA. 
 The variation in the results for rs.9705 is most likely due inherent errors in 
the extension process. Variation in the DNA levels is mostly due to irregular 
amplification and extension with the PE primers because all DNA samples had 
one SNP and one WT allele. Because the DNA acts as an internal standard, 
what we are looking for is a consistency in the variation of the levels of mRNA 
compared to DNA, which was not found in these samples. 
 Computer analysis yielded 5 different TFBS present in the promoter region 
of SLC39A8. Of those 5, 3 (AP-1, MEF-2 and NFκB) were found to contain SNPs 
present in their binding domains. The SNPs were of a variety of heterozygosities, 
some of which were exhibit a high frequency and thus a great deal of potential for 
further study (Figure 8).The SNPs found in these putative sites could impact the 
initiation of gene transcription, and therefore allelic expression. 
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CONCLUSION 
We were the first to observe that the human zinc transporter SLC39A8 is 
substantially upregulated by cytokines, in comparison to all other zinc 
transporters, in human lung epithelia.  Based on this observation we contend that 
SLC39A8 is critical in regulating zinc homeostasis and cell function during 
inflammatory stress. Further evaluation of the SLC39A8 gene revealed multiple 
frequently occurring SNPs thereby suggesting that genetic regulation may 
influence cell function. Based on this we wanted to determine if frequently 
occurring SNPs could confer changes in cell function via cis-acting genetic 
regulation.  As a first step, three candidate SNPs were identified in the SLC39A8 
gene and investigated for allelic imbalance. Our analysis was conducted in a 
collection of human small intestine samples since a large collection of human 
lung epithelia was not available at the time of this study.  
Genotype analysis of all samples was in range with the reported 
heterozygosity of each SNP studied. For SNP rs.9331 the experimental 
heterozygosity was 30% (24 out of 81 samples), while the reported value is 
48.5%. For SNP rs.9705 the experimental heterozygosity was found to be 25.6% 
(20 out of 78 samples)while the reported value is 47.8%. Finally for SNP 
rs.13107325 we found the heterozygosity to be 5.7% (5 out of 88 samples) while 
the reported value is 4.6%.(www.genecards.com) We attribute the deviation in 
heterozygosity between observed and reported percentages to a relatively small 
sample size, as many more samples would be necessary in order to get a more 
accurate measure of heterozygosity.  
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Evaluation of allelic expression imbalance demonstrated no evidence of 
imbalance in two out of the three SNPs studied (rs.9705 and rs.13107325). This 
observation suggests that these SNPs confer no direct contribution to cis-acting 
genetic regulation and likely do not directly impact mRNA expression of 
SLC39A8. As for SNP rs.9331, one sample out of 24 heterozygous samples 
demonstrated allelic imbalance. The amount of mRNA containing the variant 
allele was 46% lower than the normal allele. Although this doesn’t prove that 
rs.9331 directly impacts mRNA levels, this observation indicates that cis-acting 
gene regulation does exist in SLC39A8. The frequency of allelic imbalance was 
3.6% (1 out of 28 samples) in a repository of human small bowel samples. 
Further study would be necessary to link allelic imbalance to rs.9331 as well as 
other SNPs within the gene and the promoter region. Also conducting an AEI 
assay with human lung epithelial cells exposed to inflamatory cytokines, would 
be necessary to observe any differences in mRNA level expression. 
Evaluation of transcription factor binding sites in the promoter region 
revealed several SNPs in potential putative TNFα-inducible transcription initiation 
start sites. This suggests that other candidate SNPs that influence SLC39A8 
gene expression during inflammatory stress may exist. Promoter analysis was 
conducted in silico and will require further evaluation with methods utilized in this 
study. 
We have observed that zinc is a potent cytoprotectant in human lung 
epithelia. In particular, zinc depletion significantly increases lung epithelial cell 
death following exposure to inflammatory cytokines whereas in sharp contrast, 
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intracellular zinc repletion at the onset of inflammation prevents cell death. Our 
interpretation of these findings is that zinc uptake into the lung epithelium via zinc 
transporters is an essential innate host protective response that prevents cell 
death. Our results also suggest that abnormal zinc homeostasis, either due to 
dietary insufficiency or polymorphic variation in proteins that regulate zinc 
homeostasis may increase host susceptibility to cell damage and tissue 
dysfunction.   
Our findings demonstrate that genetic variability in SLC39A8 may be a 
cause for lung tissue dysfunction. Although the data was taken from human 
bowel samples, it identifies that cis-acting genetic imbalance exists in humans. 
Based on this, we hypothesize that “state-dependant” conditions such as 
inflammatory stress, may amplify the impact of SNPs located in the SLC39A8 
gene and play an important role in regulating zinc homeostasis during 
inflammation and the host protective response.  Further evaluation using human 
lung samples is warranted.  
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FIGURE LEGENDS 
 
Figure 1.  Expression of all 24 Human Zinc Transporters.  A total of 8 donors 
were profiled for expression levels of zinc transporters in lung epithelium tissue. 
 
Figure 2. Expression of the Human Zinc Transporter SLC39A8 is Induced 
by Tumor Necrosis Factor alpha (TNFα). SLC39A8 mRNA was significantly 
up-regulated in comparison to all other zinc transporters following 24 hour 
exposure to TNFα in primary cultures of human lung epithelial. 
 
Figure 3. A map of the human zinc transporter SLC39A8. Two high frequency 
SNPs in the 3’UTR region and one non-synonymous SNP in the coding region of 
SLC39A8 were identified as candidate SNPs for further evaluation of cis-acting 
gene regulation. 
 
Figure 4. Genotype analysis using a GC clamp assay and RT-PCR.  This is 
an example of an Allele Specific Primer. The primer extends only the G allele 
because the 3rd letter is mismatched. (Figure A) Positive samples amplified 
before PCR cycle #30 (blue line) while negative samples did not (red line). 
(Figure B) Homozygous G samples had a peak at 72˚C, homozygous A samples 
had a peak at 77˚C (due to GC tail on primer) while heterozygous samples had 
peaks at both temperatures. (Figure C) 
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Figure 5. Genotyping using a restriction enzyme and capillary 
electrophoresis. After treatment of PCR product with the restriction enzyme 
BSTZ17I, homozygous A samples had a peak at 40 bases (length of cut 
amplification product), while homozygous G samples had a peak at 65 bases 
(uncut product). Heterozygous samples had peaks at 40 and 65 bases.  
 
Figure 6.  Results of all genotype analyses for all three SNPs. Algorhythm 
for results obtained for SNP rs.9331.(Figure A) Algorhythm for results obtained 
for SNP rs.9705.(Figure B) Algorhythm for results obtained for SNP rs.13107325. 
(Figure C) 
 
Figure 7. Example of AEI Analysis in Heterozygous Samples. Patient #21: 
Ratio of G allele expression to A allele expression is consistent in mRNA (bottom 
two graphs) with DNA (top graph). Patient # 48: Ratio of G to A alleles is higher 
in DNA and consistently lower in mRNA levels.  Patient #48 demonstrates allelic 
imbalance in mRNA expression. 
 
 
Figure 8. SNPs Occur in TNFα-Inducible Transcription Factor Binding Sites. 
Results of promoter region analysis are presented.  Five transcription factor 
binding (TFB) sites were identified. SNPs were identified in AP-1, MEF-2, and 
NFκB regions. 
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Figure 1 
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Figure 2
TNFα-Induced Transporter Gene Expression
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Figure 4 
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Figure 5 
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Figure 6 
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Figure 7 
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Figure 8 
 
 
  
TFB SNP Heterozygosity TFB SNP Heterozygosity
AP-1 10642484 N/A NFkappaB 7695247 0.014+/-0.083
10683672 N/A 4146610 N/A
1381893 0.500 +/- 0.007 7655997 N/A
6844796 N/A 10683672 N/A
10461136 N/A 1350992 N/A
11940755 N/A 17212693 0.106+/-0.205
10222784 N/A 7664683 0.225+/-0.249
MEF-2 13152048 0.159+/-0.233 7376560 N/A
6846162 N/A POU NONE NONE
4699015 N/A C/EBP NONE NONE
11282386 N/A
4557261 0.448+/-0.152
7655997 N/A
7681842 N/A
7684449 N/A
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Appendix A – SNP rs. 9331 
 
sample # %G %A std dev G std dev A 
DNA 21 0.424329 0.575671 0.01401939 0.01402273 
RNA 21 0.453125 0.546875   
RNA 21 0.45493 0.545057     
DNA 25 0.436203 0.563797 0.01216472 0.01216472 
RNA 25 0.411522 0.588478   
RNA 25 0.438321 0.561679     
DNA 33 0.447766 0.552234 0.00317134 0.00317134 
RNA 33 0.440335 0.559665   
RNA 33 0.44209 0.55791     
DNA 41 0.419948 0.580052 0.01234717 0.01234756 
RNA 41 0.450067 0.549933   
RNA 41 0.437389 0.562602     
DNA 47 0.439963 0.560037 0.04031809 0.04031809 
RNA 47 0.346827 0.653173   
RNA 47 0.421842 0.578158     
DNA 48 0.437416 0.562584 0.06617857 0.06617857 
RNA 48 0.293322 0.706678   
RNA 48 0.301058 0.698942     
DNA 51 0.419054 0.580946 0.01223915 0.01223915 
RNA 51 0.420095 0.579905   
RNA 51 0.445522 0.554478     
DNA 54 0.41203 0.58797   
DNA 55 0.399138 0.600862 0.02081344 0.0209761 
RNA 55 0.366285 0.633715   
RNA 55 0.348949 0.651501     
DNA 67 0.414721 0.585279 0.00014296 0.00014056 
RNA 67 0.414689 0.585302   
RNA 67 0.415007 0.584993     
DNA 73 0.409121 0.590879 0.00802483 0.00802483 
RNA 73 0.424283 0.575717   
RNA 73 0.427536 0.572464     
DNA 75 0.39251 0.607149 0.0057938 0.00587601 
RNA 75 0.38021 0.61979   
RNA 75 0.392491 0.607509     
DNA 76 0.374549 0.625451 0.01915969 0.01915969 
RNA 76 0.401011 0.598989   
RNA 76 0.421347 0.578653     
DNA 77 0.400906 0.599094 0.05424349 0.05424349 
RNA 77 0.276367 0.723633   
RNA 77 0.378738 0.621262     
DNA 78 0.42308 0.57692 0.01801093 0.01775456 
RNA 78 0.383571 0.615429   
RNA 78 0.386324 0.613676     
DNA 79 0.500971 0.499029 0.03090212 0.03090212 
RNA 79 0.432314 0.567686   
RNA 79 0.43904 0.56096     
DNA 80 0.428618 0.571382 0.00749785 0.00749785 
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RNA 80 0.418358 0.581642   
RNA 80 0.43668 0.56332     
DNA 87 0.413745 0.586255 0.0189556 0.0189556 
RNA 87 0.396021 0.603979   
RNA 87 0.442049 0.557951     
RNA 89 0.397547 0.602453 0.014017 0.014017 
RNA 89 0.425581 0.574419     
DNA 81 0.443081 0.556919 0.02296052 0.02326726 
RNA 81 0.482194 0.517806   
RNA 81 0.427638 0.573262     
DNA 2 0.4083 0.5917 0.01864824 0.01864824 
RNA 2 0.422076 0.577924   
RNA 2 0.377471 0.622529     
DNA 8 0.41177 0.58823 0.01826237 0.0182906 
RNA 8 0.375923 0.624077   
RNA 8 0.417021 0.582879     
DNA 12 0.423459 0.576541 0.0113015 0.0113015 
RNA 12 0.400856 0.599144     
DNA 20 0.412379 0.587621 0.002391 0.002391 
RNA 20 0.417851 0.582149   
RNA 20 0.416923 0.583077     
Average DNA 0.42143726 0.57854791 0.01876364 0.01877776 
Standard Deviation 0.02379722 0.02377929 
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Appendix B – SNP rs.9705 
 
Sample # %C %T Std Dev 
DNA 1 0.341727 0.658273 0.0628745 
RNA 1 0.467476 0.532524   
DNA 12 0.403483 0.596517 0.02931156 
RNA 12 0.378073 0.621927  
RNA 12 0.332623 0.667377   
DNA 20 0.299629 0.700371 0.01968402 
RNA 20 0.347652 0.652348  
RNA 20 0.31991 0.68009   
DNA 21    
RNA 21 0.386423 0.613577 0.001368 
RNA 21 0.389159 0.610841   
DNA 33 0.395055 0.604945 0.04037903 
RNA 33 0.321838 0.678162  
RNA 33 0.300857 0.699143   
DNA 41 0.307163 0.692837 0.07849143 
RNA 41 0.260258 0.739742  
RNA 41 0.445185 0.554815   
DNA 47 0.475519 0.524481 0.06928014 
RNA 47 0.314149 0.685851  
RNA 47 0.440316 0.559684   
DNA 48 0.390201 0.609799 0.02235282 
RNA 48 0.444597 0.555403  
RNA 48 0.422805 0.577195   
DNA 51 0.400482 0.599518 0.01711019 
RNA 51 0.438168 0.561832  
RNA 51 0.435207 0.564793   
DNA 62 0.503333 0.496667 0.06034645 
RNA 62 0.388907 0.611093  
RNA 62 0.365079 0.634921   
DNA 73 0.322624 0.677376 0.02753962 
RNA 73 0.267385 0.732615  
RNA 73 0.328537 0.671463   
DNA 75 0.442297 0.557703 0.01297335 
RNA 75 0.457743 0.542257  
RNA 75 0.474071 0.525929   
DNA 76 0.459205 0.540795 0.06838156 
RNA 76 0.3267 0.6733  
RNA 76 0.304217 0.695783   
DNA 77 0.262422 0.737578 0.10142396 
RNA 77 0.506547 0.493453  
RNA 77 0.344573 0.655427   
DNA 78 0.533295 0.466705 0.05170758 
RNA 78 0.481808 0.518192  
RNA 78 0.407335 0.592665   
DNA 79 0.365365 0.634635 0.03052027 
RNA 79 0.301362 0.698638  
RNA 79 0.299906 0.700094   
   32 
DNA 80 0.326452 0.673548 0.08265053 
RNA 80 0.527097 0.472903  
RNA 80 0.403404 0.596596   
DNA 81 0.539395 0.460605 0.06257872 
RNA 81 0.447623 0.552377  
RNA 81 0.38718 0.61282   
DNA 87 0.384303 0.615697 0.07650383 
RNA 87 0.246632 0.753368  
RNA 87 0.425571 0.574429   
DNA 89 0.409816 0.590184 0.06812839 
RNA 89 0.531892 0.468108  
RNA 89 0.372316 0.627684   
Average DNA 0.39798768 0.60201232 0.0491803 
Standard Deviation 0.07707983 0.07707983 
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Appendix C – SNP rs. 13107325 
 
Sample # %C %T Std Dev  
RNA 4 0.272375 0.727625 0.015332 
RNA 4 0.303039 0.696961   
RNA 29 0.2978 0.7022 0.0048 
RNA 29 0.3074 0.6926   
DNA 30 0.3016 0.6984 0.00835 
RNA 30 0.2849 0.7151   
DNA 38 0.2973 0.7027 0.0015 
RNA 38 0.3003 0.6997   
RNA 72 0.267 0.733 0.01585 
RNA 72 0.2987 0.7013   
DNA 74 0.2763 0.7237 0.00545 
RNA 74 0.2654 0.7346   
Average DNA 0.29173333 0.70826667 0.008547 
Standard  Deviation 0.01353748 0.01353748 
 
 
